Among the 17 mammalian synaptotagmin (Syt) isoforms 1 , Syt IV stands out as an anomaly. Syt proteins have attracted great interest as Ca 2+ sensors in regulated exocytosis and neurotransmitter release 2 , but Ca 2+ binding to mammalian Syt IV has not been detected 3 and Ca 2+ fails to trigger tighter binding of Syt IV to key effectors that are engaged by other Ca 2+ -sensing Syt proteins [4] [5] [6] . Moreover, Syt IV inhibits the action of Syt I in Ca 2+ -triggered liposome fusion 7 . Some studies have reported Syt IV's presence on synaptic vesicles 8, 9 , but others have disputed this claim 10, 11 . Indeed, with reports of Syt IV in the Golgi 10 , astrocytes 12 and postsynaptic muscle fibers in Drosophila 13 , considerable doubts remain about whether Syt IV has any role in neurotransmitter release. Syt IV overexpression reduces, but does not eliminate, release in PC12 cells 14 . In Drosophila, Syt IV reduces release at synapses 15 and modifies nerve terminal fusion pores 16 , but a postsynaptic function has also been reported, with Drosophila Syt IV regulating the release of a retrograde transmitter from muscle fibers 17 . A study in rodent hippocampal neurons reported that Syt IV had no effect on synaptic transmission 9 .
Elucidating the physiological function of Syt IV requires a native preparation that expresses substantial levels of this protein. Syt IV is relatively scarce in the brain 18 , but we found high levels in posterior pituitary nerve terminals. In experiments with this neuropeptidesecreting structure in wild-type and Syt IV knockout mice, we localized Syt IV to dense-core vesicles (DCVs) and microvesicles and found that Syt IV altered Ca 2+ -triggered exocytosis of both. Furthermore, Syt IV altered fusion pores and regulated the kinetics of rapid compensatory endocytosis. Thus, Syt IV participates in several distinct secretory functions in nerve terminals, establishing Syt IV as an important regulator of release from nerve terminals.
RESULTS

Syt IV localization
To determine the distribution of Syt IV, we performed immunoblots of neuronal structures in mouse. Cortex, cerebellum, hippocampus and striatum had very low levels of Syt IV (Fig. 1a) . In contrast, the pituitary yielded a strong signal, consistent with reports of high levels of Syt IV-encoding RNA 18 . When the pituitary was separated, strong signals were seen in both the neuro-intermediate lobe (posterior pituitary/neurohypophysis and intermediate lobe) and anterior pituitary (adenohypophysis); the neuro-intermediate lobe contained about four-to eightfold more Syt IV protein than the anterior pituitary (Fig. 1b) . Both posterior and anterior pituitaries from Syt IV knockout mice showed faint background signals resulting from weak crossreactivity of the antibody to Syt IV with another protein of slightly lower molecular mass, which was noted in the manufacturer's data for this reagent.
The presence of Syt IV in the pituitary is important because the neurohypophysis consists primarily of nerve terminals emanating from the hypothalamus. Thus, the high Syt IV levels there suggest a role in neurosecretion. To determine whether Syt IV resides on secretory vesicles, we performed immuno-organelle isolation from the rat pituitary (to obtain more tissue). Neuro-intermediate lobes of [5] [6] [7] [8] [9] [10] [11] [12] rats were pooled, homogenized, immunoprecipitated with antibodies to Syt I or synaptophysin, resolved with SDS-PAGE and probed for Syt I, Syt IV and synaptophysin. The antibody to Syt I pulled down Syt I and synaptophysin, as expected, but also pulled down most of the Syt IV in the lysate (Fig. 1c) . Antibody to synaptophysin pulled down synaptophysin and Syt I, along with a substantial fraction of lysate Syt IV. These experiments demonstrated the presence of Syt IV on secretory organelles in peptidergic nerve terminals. Antibody to synaptophysin pulled down a smaller fraction of lysate Syt IV than did antibody to Syt I, and because synaptophysin has not been detected on DCVs, whereas Syt I is present on both microvesicles and DCVs 19 , these results suggest that Syt IV localizes to both DCVs and microvesicles, but with more Syt IV being present on DCVs.
We also investigated the localization of Syt IV using electron microscopy and immuno-gold labeling. Syt IV label appeared on both DCVs and microvesicles, with much less Syt IV label being present in control (without primary antibody ) and Syt IV knockout nerve terminals (Fig. 2a-c) . Wild-type nerve terminals showed a significantly higher (P o 0.01) fraction of label on microvesicles and DCVs and a much lower fraction of free label (unassociated with vesicles; Fig. 2d ). These differences do not reflect differences in vesicle number, as images from wild-type and knockout had essentially the same number of vesicles. Wild-type images contained 233.4 ± 19.5 microvesicles versus 227.7 ± 18.3 in knockout (P ¼ 0.41) and 90.5 ± 3.9 DCVs versus 86.6 ± 3.6 in knockout (P ¼ 0.23) (76 wild-type and 89 knockout images taken at 40,000Â). Thus, genetic ablation of Syt IV does not alter vesicle numbers in pituitary nerve terminals.
Electron microscopy with immunogold label was also conducted on lightly fixed material (4% formaldehyde, 0.1% glutaraldehyde, wt/vol; Syt IV antibody dilution 1:1,000), to allow conventional 15-nm gold particles to penetrate the tissue (instead of the ultra-small 1-nm particles used in Fig. 2 ; see Methods). The lighter fixation did not reveal microvesicles, but showed the cores of DCVs. We found that 19.4 ± 4.5% of the DCVs in wild-type nerve terminals were labeled compared with 4.42 ± 0.37% in knockouts (P ¼ 0.04), with more than twice the percentage of label on DCVs in wild-type compared with knockout vesicles (data not shown). Vesicle sizes were also compared and these data are evaluated below. These experiments establish the presence of Syt IV on both types of secretory organelles of the posterior pituitary and motivated us to further investigate how this protein alters physiological function in nerve terminals.
Calcium current
Because Ca 2+ entry through voltage-gated Ca 2+ channels triggers exocytosis in nerve terminals, including those of the posterior pituitary, we measured Ca 2+ current as a prelude to our experiments on exocytosis. Whole-terminal patch-clamp recordings with voltage steps from -50 to 50 mV (holding potential -80 mV) elicited Ca 2+ currents that varied with voltage and were maximal at B10 mV (Fig. 3a) . Normalized current-voltage plots showed the same voltage dependence in wild-type and knockout terminals (Fig. 3b) .
To compare Ca 2+ -current density, we plotted the peak Ca 2+ current (elicited by 10-mV pulses) versus nerve terminal capacitance (capacitance is proportional to membrane area) (Fig. 3c) . All recordings were made in 10 mM Ca 2+ so that wild-type and knockout terminals could be compared. Linear regression yielded a steeper slope for wild-type nerve terminals. The average Ca 2+ -current density was more than threefold greater for wild types (wild type, 100.8 ± 18.3 pA/pF; knockout, 31.1 ± 5.0 pA/pF; P ¼ 0.003). In both wild-type and knockout nerve terminals, Ca 2+ current inactivated with a time constant of B40 ms. Thus, nerve terminals lacking Syt IV have much lower Ca 2+ current per unit area of plasma membrane, but the Ca 2+ channels have the same activation and inactivation properties. 20 . We made recordings of Ca 2+ current and capacitance in wild-type and Syt IV knockout nerve terminals (Fig. 4a) .
The capacitance immediately following a voltage step was higher than before, indicating that exocytosis had occurred. Endocytosis then brought the capacitance back to its baseline level in a few seconds. Larger Ca 2+ currents generally evoked more exocytosis; pulsing to near 10 mV produced the largest capacitance increases. From the Ca 2+ current, we calculated total Ca 2+ influx by integration, enabling us to quantify exocytosis and to relate this to Ca 2+ entry for each pulse. We plotted these two quantities to illustrate how the capacitance increase varied with Ca 2+ influx (Fig. 4b) .
In wild-type nerve terminals, capacitance changes increase roughly linearly with Ca 2+ influx (longer pulses than those employed here saturate exocytosis, see ref. 20) . In Syt IV knockouts, the relationship was more complicated. With low Ca 2+ influx, Syt IV knockout nerve terminals showed larger capacitance changes than wild types and the points in the low Ca 2+ -influx region fell along a steep line. At higher Ca 2+ influx, however, this plot was not nearly as steep. A statistical analysis of our data (by k-means clustering, see Methods) revealed two groups of knockout capacitance recordings, each following a distinct linear relationship (Fig. 4b) . In contrast, the wild-type data showed no Figure 3a ,b. Capacitance changes were plotted against Ca 2+ influx (the integral of the Ca 2+ current). The wild-type plot was roughly linear and the entire dataset was fitted to one line. In the knockout plot, capacitance increased steeply with Ca 2+ influx at low Ca 2+ influx, but at high Ca 2+ influx the knockout data fell along a line with a much lower slope. k-means clustering analysis showed two clusters in the knockout plot (KO1 and KO2) (Supplementary Data online and Fig. 1 ). Each cluster was fitted separately to a line (fitting parameters for all three plots are in the figure) . Including the origin in the fits gave essentially the same results. (c) Capacitance changes were compared for Ca 2+ influx o7 pC and 7-30 pC. For the o7 pC group, the recordings from wild-type terminals showed smaller capacitance changes than those from knockout terminals (6.0 ± 0.7 fF (n ¼ 44) versus 11.0 ± 1.3 fF (n ¼ 48), respectively). For the 7-30 pC group, the result was reversed (17.4 ± 1.4 fF (n ¼ 25) versus 12.5 ± 1.2 fF (n ¼ 21)). * indicates P o 0.001 and P ¼ 0.004 for the low and high Ca 2+ -entry capacitance changes, respectively. Mean Ca 2+ influxes for o7 pC were 2.1 ± 0.3 pC for wild type and 2.4 ± 0.3 pC for knockout; for the 7-30 pC range, mean Ca 2+ influxes were 13.4 ± 1.1 pC for wild type and 14.5 ± 1.2 pC for knockout. Note that the nerve terminals were similar in size (wild-type capacitance, 5.2 ± 0.8 pF; knockout capacitance, 5.4 ± 0.6; P ¼ 0.4). Error bars and errors in the legend represent s.e. Figure 3 Voltage-dependent Ca 2+ current in pituitary nerve terminals. (a) Ca 2+ current in a knockout nerve terminal evoked by 200-ms voltage steps from a holding potential of -80 mV to test potentials (-50 to 50 mV in increments of 10 mV). Bathing [Ca 2+ ] was 10 mM for all the experiments of this figure, for both wild type and knockout. Note that, as part of the capacitance measurement protocol, a sine wave (data not shown) was applied to the patch-clamp command potential immediately before and after the voltage steps. Dashed lines indicate the baseline calculated as the leak current at the holding potential of -80 mV. (b) Average peak Ca 2+ current (after leak subtraction) with s.e. plotted versus test potential normalized to the maximum value (at 10 mV). Normalized plots show that the voltage dependence of Ca 2+ current was the same between wild type (n ¼ 9) and knockout (n ¼ 9). (c) Maximum Ca 2+ current (at 10 mV) for a given nerve terminal was plotted against whole-terminal capacitance for that nerve terminal (black diamonds, wild type; open squares, knockout). Linear regression yielded an Bthreefold greater slope for wild type than for knockout, and this difference was not affected by constraining the fits to pass through the origin. Inset, mean Ca 2+ -current density (averages of the ratio of peak Ca 2+ current to nerve terminal capacitance with s.e.) was significantly larger in wild type than in knockout (P ¼ 0.003). The KO2 group resembled wild type, whereas the KO1 group followed a much steeper slope and fell entirely in the low Ca 2+ -influx region. Clustering analysis indicated that wild-type and knockout nerve terminals responded differently to high and low Ca 2+ influx. To explore this difference without using cluster analysis, we took all of the wildtype and knockout data and sorted on the basis of a Ca 2+ influx at either o7 pC or 7-30 pC. In each group, the mean Ca 2+ influxes were similar for wild-type and knockout terminals (P ¼ 0.24 and 0.21 for low and high Ca 2+ influx, respectively), but the mean capacitance changes differed significantly (P o 0.001 and P ¼ 0.004 for low and high Ca 2+ -entry, respectively; Fig. 4c ). In the low Ca 2+ -influx region, the mean capacitance change was higher for knockout terminals (wild type: 6.0 ± 0.7 fF, n ¼ 44; knockout: 11.0 ± 1.3 fF, n ¼ 48, P o 0.001), whereas the mean capacitance change was higher in wild-type terminals for high Ca 2+ influx (wild type: 17.4 ± 1.4 fF, n ¼ 25; knockout: 12.5 ± 1.2 fF, n ¼ 21, P ¼ 0.004). Thus, in the absence of Syt IV, low Ca 2+ influx produced more exocytosis, but high Ca 2+ influx reversed this trend.
Endocytosis
Capacitance increases elicited by voltage steps decay back to baseline in a form of compensatory endocytosis that is commonly observed in nerve terminals [20] [21] [22] . To see whether Syt IV influences this form of membrane retrieval, we evoked exocytosis with 200-ms voltage pulses (ranging from -20 to 40 mV) and compared the kinetics of the ensuing endocytosis. The extent of the compensatory endocytosis was very similar between wild-type and knockout terminals. After a depolarizing pulse, the capacitance increase decayed by 91.7 ± 5.1% and 87.3 ± 2.1% in wild types and knockouts, respectively (P ¼ 0.26).
In the majority of nerve terminals, capacitance decays had two exponential components (Fig. 5a,b) , with a slow time constant of 1.4-2.0 s and a fast time constant of 0.1-0.2 s. Endocytosis in knockouts was generally faster than in wild types (as we saw by plotting the double exponential fits of Fig. 5a,b; Fig. 5c ). The time constants were similar (endocytosis in the groups denoted as KO1 and KO2 above was indistinguishable, and so these data were combined; Fig. 5d ), but the ratio of the amplitudes of the slow-to-fast component in wild-type nerve terminals of 1.8 ± 0.2 (n ¼ 20) was significantly larger than the ratio of 1.1 ± 0.2 (n ¼ 25) in knockouts (P o 0.001; Fig. 5e ). Thus, Syt IV influences rapid endocytosis in nerve terminals. The rates of each component were invariant, but knocking out Syt IV favored the fast component of endocytosis over the slow component.
Single-vesicle capacitance steps
Fusion of single vesicles produced stepwise changes in membrane capacitance 23, 24 . We recorded capacitance in cell-attached patches from wild-type (Fig. 6a) and knockout nerve terminals (Fig. 6b) and saw both upward exocytosis steps and downward endocytosis steps (Fig. 6) . The distributions of step sizes for exocytosis were indistinguishable between wild-type and knockout terminals (Fig. 7a) . Both distributions had two components that corresponded to the microvesicles and DCVs that were seen in electron microscopy. To separate the analysis of microvesicles and DCVs, we divided capacitance steps according to a cutoff value of 80 aF (this value was smaller than that used for rat nerve terminals 24 because of the smaller vesicles in mouse). Microvesicle steps averaged 36.0 ± 0.8 aF (n ¼ 452) in wild types and 34.7 ± 0.9 aF (n ¼ 351) in knockouts (P ¼ 0.13). DCV steps averaged 211.6 ± 16.4 aF (n ¼ 186) in wild types and 187.3 ± 16.3 aF (n ¼ 139) in knockouts (P ¼ 0.15; Fig. 7b ). Assuming spherical vesicles and a specific membrane capacitance of 0.9 mF cm -2 (ref. 25) , we computed vesicle diameters for each step. Microvesicles had essentially identical diameters, 34.8 ± 0.4 nm and 34.1 ± 0.4 nm for wild types and knockouts, respectively. DCVs had diameters of 81.3 ± 2.2 nm and 76.7 ± 2.3 nm for wild types and knockouts, respectively, which were not as similar as the microvesicle diameters, but were not significantly different (P ¼ 0.12 for microvesicles and P ¼ 0.07 for DCVs).
We returned to our electron microscopy images (Fig. 2) to measure vesicle diameters and compared them with those measured from capacitance (Fig. 7c,d ). Microvesicle diameters were very similar across methods and animals (electron microscopy yielded 36.3 ± 0.2 nm (n ¼ 868) for wild-type and 36.1 ± 0.3 (n ¼ 479) for knockout vesicles; P ¼ 0.25). The slightly larger electron microscopy values could be accounted for by a specific membrane capacitance that is slightly lower than the 0.9 mF cm -2 value 25 that we used in the conversion (such a small change is well within the tolerance of the measurement). In contrast, the disparity between electron microscopy and capacitance diameters was greater for DCVs (89.9 ± 0.5 nm (n ¼ 2,020) for wild-type and 106.7 ± 1.2 nm (n ¼ 635) for knockout terminals; P o 0.0001). Furthermore, the mean diameter of DCVs in the electron microscope was significantly greater in knockouts than in wild types. These differences are unlikely to reflect different values of the specific membrane capacitance of DCVs; a lower value could bring the numbers for DCV diameter in line for wild type or knockout, but not for both. Previous reports have also noted larger DCVs in the presence of elevated Syt IV levels 26 , and the maturation of DCVs 27 offers a more satisfying explanation. Capacitance probably selects exocytosis-competent DCVs that are more mature and smaller. Because Syt IV functions in DCV maturation 28 , knockout nerve terminals could contain a larger proportion of less mature and larger DCVs.
Depolarizing nerve terminals with 120 mM KCl increased the fusion rate of both microvesicles and DCVs in both wild-type and knockout nerve terminals (Fig. 8a) . As in rat posterior pituitary 24 , about 60% of the nerve terminals (both wild type and knockout) were insensitive to KCl depolarization, as a result of either high initial activity or the depth of the nerve terminal buried in the slice. In patches where KCl depolarization enhanced exocytosis, the enhancement was greater in knockout than in wild-type terminals for both microvesicles and DCVs (Fig. 8b) . Thus, the inhibitory action of Syt IV on exocytosis manifests as lower fusion rates of both microvesicles and DCVs. These results agree with our findings that Syt IV is present on both types of vesicles ( Figs. 1 and 2) . The effect of Syt IVon exocytosis in patches was similar to the results of our whole-terminal recordings for low Ca 2+ influx (Fig. 4) . This is reasonable because, although the stimulation protocol under whole-terminal voltage clamp was quite different from that in patches, three factors all work to reduce Ca 2+ in patch versus wholeterminal recordings: the slower voltage change with KCl depolarization will inactivate Ca 2+ channels, Ca 2+ enters a nerve terminal through channels outside of the patch, and KCl depolarization might not move the membrane to the peak of the Ca 2+ current-voltage curve.
Fusion pores and kiss and run
Capacitance recordings provide information about fusion pores and kiss-and-run exocytosis. During KCl application, upward capacitance steps were occasionally followed in a few seconds by a downward step (Fig. 9) . These capacitance flickers are a hallmark of kiss-and-run exocytosis, as they indicate a reversal of the opening of a fusion pore 23, 24, 29 . Reversals occurred within 2.5 s in about 10% of the upward steps in wild-type vesicles (29 microvesicle steps and 34 DCV steps) and 13.5% of the upward steps in knockout vesicles (30 microvesicle steps and 36 DCV steps). The variability from patch to patch was too great to evaluate the importance of this difference. The amplitude of an upward step was tightly correlated with the ensuing downward step ( Supplementary Fig. 2 online) , indicating that the membrane does not flow between the vesicle and cell surface during these events 24 . Both microvesicle and DCV kiss-and-run events had similar capacitances and durations in wild-type versus knockout vesicles (wild-type microvesicle: 45.1 ± 3.3 aF, 629 ± 127 ms, n ¼ 29; wild-type DCV: 248 ± 30 aF, 462 ± 166 ms, n ¼ 34; knockout microvesicle: 42.2 ± 3.3 aF, 745 ± 161 ms, n ¼ 30; knockout DCV: 244 ± 54 aF, 459 ± 100 ms, n ¼ 36).
Lock-in amplifier signals recorded during kiss-and-run events can be used to calculate fusion pore conductance (see Methods). DCV kissand-run events in wild-type nerve terminals had fusion pores with nearly twice the conductance of those in knockout (wild type: 97.5 ± 17.7 pS, n ¼ 29; knockout: 54.2 ± 8.5 pS, n ¼ 31; P ¼ 0.016; Fig. 9b) . Microvesicle kiss-and-run events had similar fusion pore conductances in wild-type and knockout vesicles (wild type: 17.1 ± 4.0 pS, n ¼ 21; knockout: 13.4 ± 1.4 pS, n ¼ 15; P ¼ 0.20), but the smaller size of microvesicles made it considerably more difficult to detect their fusion pores, so the possibility of a real difference cannot be ruled out. The diameter of a fusion pore can be estimated from the conductance with the equation
, where d p ¼ pore diameter, r ¼ fluid resistivity (100 Ocm for physiological saline) and l ¼ pore length (15 nm) 30 . DCV pores had diameters of 1.22 ± 0.12 nm for wild-type and 0.95 ± 0.06 nm for knockout vesicles (P ¼ 0.026), whereas microvesicle pores had similar diameters for wild-type (0.53 ± 0.05 nm) and knockout vesicles (0.49 ± 0.03 nm, P ¼ 0.29).
DISCUSSION
Our results demonstrate that Syt IV resides on DCVs and microvesicles in peptidergic nerve terminals of the posterior pituitary. Comparisons between the nerve terminals of wild-type and Syt IV knockout mice showed that this protein can either enhance or inhibit Ca 2+ -triggered exocytosis, depending on the amount of Ca 2+ entry. Syt IValso changes the conductance of DCV fusion pores and modifies the kinetics of endocytosis. Prior studies have suggested diverse locations and functions for Syt IV, which is expressed in various cell types. We focused on Syt IVat biologically relevant levels in its native environment, and many of the disparities in the literature probably stem from technical aspects of the various expression protocols and differences in the targeting of an expressed protein in different experimental systems. The high levels of Syt IV that we observed in the posterior pituitary compared with other brain regions indicate that it has a special role in neuropeptide function. Given the similarities between synaptic vesicles and endocrine microvesicles 19, 31 , our finding that Syt IV resides on microvesicles and alters their exocytosis raises the possibility of a direct role for Syt IV in regulating synaptic transmission.
Exocytosis
Eliminating Syt IV enhanced exocytosis of microvesicles and DCVs (Fig. 8) . In whole-terminal recordings from knockout nerve terminals, low levels of Ca 2+ entry were more effective at triggering exocytosis than in wild-type terminals and higher levels of Ca 2+ entry were less effective. Thus, the presence of Syt IV on microvesicles and DCVs affects the Ca 2+ dependence of their fusion. An inhibitory effect on exocytosis is consistent with the reduction of norepinephrine 14 and growth hormone 32 release that is seen in PC12 cells overexpressing Syt IV. In astrocytes, however, endogenous Syt IV makes a positive contribution to Ca 2+ -triggered exocytosis 12 and knocking down Syt IV in a gonadotrope cell line reduced release 33 . It should be noted that the gonadotrope study employed caged Ca 2+ to trigger release with very high levels of intracellular [Ca 2+ ]. This may be comparable to the high Ca 2+ influx seen here, where release was greater in wild type (Fig. 4c) . Fusion pore properties were compared between wild-type and knockout nerve terminals. G p was smaller in knockout nerve terminals for DCVs. Kiss-and-run events were seen during KCl application as in Figure 6 (error bars are s.e.).
The cytoplasmic domain of Syt IV strongly inhibited the Ca 2+ -dependent stimulation of soluble N-ethylmaleimide sensitive factor-attachment receptor (SNARE)-mediated liposome fusion by Syt I 7 . In contrast, Syt IV expression had no effect on synaptic function in hippocampal cultures 9 . Reports on the function of the Drosophila Syt IV homolog are also quite divergent 15, 17, 34 , but the primary structures of rodent and Drosophila Syt IV differ sufficiently to raise questions about the relevance of these findings to data presented here.
The C2A and C2B domains of Syt I have pockets in which several acidic amino acids coordinate the binding of Ca 2+ , but in loop 3 of the C2A domain of Syt IV, an important Ca 2+ -coordinating aspartate is replaced by a serine that disrupts Ca 2+ binding. Furthermore, loop 1 of the C2B domain of Syt IV is too flexible to form a stable Ca 2+ -binding pocket, and the critical residues in loop 3 are improperly oriented 3 . Presumably, these structural differences account for the failure of Ca 2+ to stimulate the association of Syt IV with t-SNAREs and liposomes of biologically relevant phospholipid compositions [3] [4] [5] 26 . However, Syt IV binds t-SNAREs in the absence of Ca 2+ (ref. 26) , and if this interaction creates a non-fusogenic complex, this could interfere with the incorporation of Syt I into a fusogenic complex. Although Syt IV reduced exocytosis at low levels of Ca 2+ influx, high Ca 2+ influx reversed this inhibition. The presence of multiple Syt isoforms has been proposed as a mechanism for tuning the Ca 2+ sensitivity of release 8, 26, 35, 36 . Syt IV appears to broaden the Ca 2+ sensitivity, expanding the range of [Ca 2+ ] that regulates exocytosis. Alternatively, there could be a kinetic explanation: if Syt IV provides a slow, nonproductive side pathway, speeding up a competing productive pathway by higher [Ca 2+ ] could overcome this inhibition. The greater exocytosis in wild-type nerve terminals at high Ca 2+ influx (Fig. 4c ) may indicate that Syt IV can exert a positive effect on exocytosis with sufficient Ca 2+ . This would require either in vivo Ca 2+ -binding properties of Syt IV that differ from those seen in vitro 3 or some form of facilitation by Syt IV of a low-affinity Ca 2+ sensor.
Syt IV knockout nerve terminals had less than one-third the Ca 2+ -current density of wild types. This probably does not reflect direct interactions between Syt IVand Ca 2+ channels, as overexpression of Syt IV in PC12 cells does not change Ca 2+ current 14 . Furthermore, the voltage dependence and inactivation of Ca 2+ current were identical in wild-type and knockout terminals. Thus, it is more likely that reduced Ca 2+ current is an adaptive response that compensates for the absence of Syt IV. Electrical stimulation and protein kinase C activation have been reported to recruit intracellular Ca 2+ channels to the plasma membrane 37, 38 , and Syt IV could influence Ca 2+ -channel density by regulating this form of trafficking.
Fusion pore properties
Amperometric recording in PC12 cells has suggested that Syt IV alters the stability of fusion pores formed by catecholamine-containing DCVs 14, 32 . However, the failure of Syt IV overexpression to alter synaptic currents in hippocampal neurons was interpreted as indicating that Syt IV has no effect on fusion pores in synaptic vesicles 9 . Capacitance recordings showed that the presence of Syt IV increased kiss-and-run DCV fusion pore conductances from 54 to 97 pS (Fig. 9b) , but changes in microvesicle fusion pore conductances could not be detected. Thus, the apparent discrepancy between PC12 cells 14 and neurons 9 may reflect a selective effect of Syt IV on DCV fusion pores. Syt IV altered unitary synaptic currents in Drosophila neuromuscular junction by changing fusion pores 16 . Synaptic vesicle fusion pore conductances are much larger in the calyx of Held 39 than the microvesicle fusion pores in the posterior pituitary, and the calyx of Held contains high levels of Syt II 40 . This is another instance where Syt isoform expression is correlated with differences in fusion pore properties.
In PC12 cells, Syt IVoverexpression has a number of effects on fusion pores. The brief B1-ms fusion pore openings that lead to full fusion became shorter 14 , but these events are too brief to observe with the lower time resolution of capacitance recording. Syt IValso enhanced the appearance and prolonged the duration of kiss-and-run events associated with a distinctly smaller class of fusion pores 26 . These events lasted much longer than fusion pore openings that lead to full fusion, so if Syt IV had similar effects in the posterior pituitary, we should have seen similar changes. However, in these nerve terminals, fusion pores were larger when Syt IV was present. More recently, we have performed capacitance recordings in PC12 cells to examine long-duration kiss-andrun events that were similar in form to those investigated here in nerve terminals. For these events, overexpressing Syt IV in PC12 cells increased the fusion pore conductances in the same way that natural levels of Syt IV expression did in nerve terminals (data not shown). Thus, Syt IV can have very different effects on different types of fusion pores.
Endocytosis
Nerve terminals show a variety of forms of endocytosis that can be engaged by different levels of electrical activity 41 . Capacitance recording has revealed a rapid form of endocytosis that is tightly coupled to Ca 2+ -triggered exocytosis [20] [21] [22] . Our results indicate that Syt IV alters this rapid component of endocytosis. Syt I also functions in nerve terminal endocytosis; ablation of Syt I leads to vesicle accumulation in C. elegans nerve terminals 42 and impairment of endocytosis in nerve terminals of mice 43 and Drosophila 44 .
In the posterior pituitary nerve terminals studied here, endocytosis was resolved into two distinct exponential components. Removal of Syt IV favored the faster of the two, but did not alter either time constant. Thus, Syt IV regulates the choice between these two pathways and this is consistent with its proposed function in regulating the choice between two different pathways of exocytosis in PC12 cells 26 . A role in slowing down endocytosis would compensate for the downregulation of exocytosis and could help coordinate the regulation of these two membrane-trafficking processes. Thus, as with Syt I and its dual functions in exocytosis and endocytosis, employing another molecule, Syt IV, in both processes helps maintain the area of a nerve terminal's cell surface 43 .
Kiss-and-run could represent one of the components of endocytosis at nerve terminals, but the mean lifetime of kiss-and-run capacitance flickers (Fig. 8b) was two-to threefold longer than the time constant of the fast component of endocytosis in whole-terminal recordings (Fig. 5d) . Lifetimes based on single-vesicle analysis generally overestimate the true lifetime because of failures to detect the briefest events. If the fast component in whole-terminal endocytosis does indeed represent kiss-and-run, then Syt IV could slow endocytosis by favoring the slower non-kiss-and-run pathway.
Syt IV and endocrine transitions
We found that Syt IV altered function in peptidergic nerve terminals at a number of levels. The posterior pituitary undergoes substantial structural reorganization as part of the functional plasticity of the hypothalamic-neurohypophysial system in the control of reproduction and fluid balance 45 . As an inducible and highly regulated protein 18 , Syt IV levels could change during these endocrine transitions to alter the release of the two neurohypophysial peptides, oxytocin and vasopressin. Because Syt IV inhibited exocytosis triggered by low Ca 2+ influx and enhanced exocytosis triggered by high Ca 2+ influx, Syt IV expression will reduce or enhance neuropeptide secretion depending on the intensity of the drive from the hypothalamus. Action-potential frequency and temporal pattern are important biological parameters in the regulation of neurohypophysial peptide release 46 . Thus, by modulating the Ca 2+ dependence of release, changes in Syt IV levels would tune the sensitivity of release to the properties of the action potential drive from the hypothalamus. It is thus of considerable interest that Syt IV levels have been linked to singing behavior in songbirds 47 , and it will be interesting and important to evaluate hypothalamic and neurohypophysial Syt IV levels in animals under water and salt stress and in different reproductive states.
METHODS
Animals. Wild-type and Syt IV knockout mice (Syt4 -/-) and Sprague-Dawley rats were anesthetized and decapitated according to procedures approved by the Animal Care and Use Committee of the University of Wisconsin. Syt IV knockout mice 48 were provided by H. Herschman (University of California Los Angeles). Genotype was confirmed by PCR of tail-clip DNA.
Western blots and immuno-organelle isolation. Cortex, cerebellum, striatum, hippocampus and anterior and posterior pituitary were homogenized using a Polytron homogenizer in 50-500 mL of lysis buffer (25 mM HEPES (adjusted to pH 7.5 with NaOH), 150 mM NaCl, 1% Triton X-100 and 0.5% cholic acid, wt/ vol) with protease inhibitors (leupeptin, pepstatin, aprotinin and PMSF).
Homogenates were centrifuged at 14,000g for 15 min at 4 1C. Pellets were discarded and protein concentrations of the supernatants (total cell lysates) were determined using the BCA assay (Pierce Chemical). For SDS-PAGE and western blotting, lysates were adjusted to the same protein concentration with lysis buffer, resolved on 12% SDS-PAGE, transferred to nitrocellulose membranes and probed with a rabbit polyclonal antibody to Syt IV (Synaptic Systems) at a 1:500 dilution. Immunolabeled bands were visualized using a horseradish peroxidase-conjugated secondary antibody and enhanced chemiluminescence (Amersham Pharmacia Biotech).
Protein G beads (30 mL, 50% slurry in TBS, wt/vol) were incubated overnight with 3 ml of monoclonal antibody to Syt I (Cl 41.1) or synaptophysin (Cl 7.2) or control mouse ascites fluid. Beads were then washed three times in TBS solution (10 mM Tris (pH 7.4) and 150 mM NaCl). The posterior pituitary was dissected from 5-12 rats and homogenized in TBS with protease inhibitors using a glass-teflon homogenizer. The homogenate was centrifuged at 1,500g for 10 min, the supernatant was collected and protein concentration was determined by BCA assay. Lysates for immunoprecipitation were split evenly between antibody and control and incubated overnight at 4 1C with rotation. Samples were washed three times with TBS and bound protein was eluted by boiling in sample buffer (2% SDS, 6% glycerol, 1% b-mercaptoethanol, 0.004% bromomethyl blue (wt/vol for all) and 50 mM Tris, pH. 6.8). Roughly 20 mg of total and supernatant (B1/15 of the reaction) and 100% of the pellet were resolved by SDS-PAGE and immunoblotting. The average total protein for each immunoprecipitation was B300 mg. Nitrocellulose membranes were probed using the antibodies described above to Syt I, synaptophysin or Syt IV.
Posterior pituitary slices. Mouse posterior pituitary slices were prepared by the same procedures used for rat 20, 24 . We cut 70-mm-thick slices with a vibratome at B0 1C and maintained them in ice-cold artificial cerebrospinal fluid consisting of 125 mM NaCl, 4 mM KCl, 1.25 mM NaH 2 PO 4 , 26 mM NaHCO 3 , 2 mM CaCl 2 and 1 mM MgCl 2 bubbled with 95% O 2 /5% CO 2 .
Electrophysiology. An EPC-7 patch clamp amplifier was used in wholeterminal and cell-attached patch recordings. An SR-830 lock-in amplifier (Stanford Research Systems) was connected to the patch-clamp amplifier to enable capacitance measurement 49 . Signals were digitized with an ITC-16 interface connected to a Macintosh computer running Igor (WaveMetrics) and Pulse Control XOPs 20 .
In whole-nerve terminal recordings, slices were perfused with 121 mM NaCl, 4 mM CsCl, 10 mM CaCl 2 , 1 mM MgCl 2 , 0.003 mM tetrodotoxin, 20 mM tetraethylammonium chloride (TEA), 2 mM 4-aminopyridine and 10 mM HEPES, pH 7.3. Higher Ca 2+ (20 or 40 mM) concentrations were used in some Syt IV knockout recordings to produce high Ca 2+ influxes comparable with those in wild type. Patch pipettes pulled from borosilicate capillaries (outer diameter ¼ 1.5 mm, inner diameter ¼ 1.15 mm, Garner Glass) had resistances of 2-5 MO. Pipettes contained 130 mM CsCl, 10 mM NaCl, 0.2 mM EGTA, 15 mM TEA, 4 mM magnesium-ATP, 0.3 mM GTP and 10 mM HEPES, pH 7.3. In whole-terminal recordings, capacitance and series resistance were determined by transient cancellation (series resistances, 5-15 MO). All data were collected in 10 min of break-in to avoid washout during whole-terminal dialysis. During that time, Ca 2+ current showed little if any washout. Leak current (measured at -50 mV) was often o1 pA and rarely exceeded 10 pA. Recordings with leak 420 pA were not used. Leak current at -50 mV was scaled according to voltage using a reversal potential of 0 mV and subtracted from the Ca 2+ current.
A sinusoidal voltage (2 kHz, 15 mV r.m.s.) from the lock-in amplifier was superimposed on the patch-clamp amplifier command potential for whole-terminal capacitance and lock-in amplifier outputs were low-pass filtered with a 10-ms time constant. During depolarization, the sine wave was stopped with a transistor-transistor logic signal to allow Ca 2+ -current recording. Ca 2+ current was low-pass filtered (usually at 3 kHz) and read into the computer.
Cell-attached patch capacitance recording followed previously described procedures 49 . A sinusoidal voltage (20-30 kHz, 100-200 mV r.m.s.) from the lock-in amplifier was superimposed onto a holding potential of 0 mV. The patch-clamp amplifier output was fed into the lock-in amplifier through a 5:1 voltage divider. Lock-in amplifier outputs were low-pass filtered at 3 ms. The bathing solution contained 125 mM NaCl, 4 mM KCl, 10 mM CaCl 2 , 2 mM MgCl 2 and 10 mM HEPES, pH 7.3. The pipette solution was the same, but with the addition of 15 mM TEA and 3 mM tetrodotoxin. To reduce noise, patch pipettes were pulled from thick-wall borosilicate glass capillaries (outer diameter ¼ 1.5-1.7 mm, inner diameter ¼ 0.85 mm), heavily coated with Sylgard and filled with the minimum amount of solution that allowed electrical contact with the Ag/AgCl wire. Nerve terminals were depolarized with puffs of high KCl solution (120 mM KCl, 10 mM NaCl, 10 mM CaCl 2 , 2 mM MgCl 2 and 10 mM HEPES, pH 7.3) from a micropipette 10-20 mm away using a Picospritzer (Parker Hannifin).
In whole-terminal and cell-attached patch recordings, the phase of the lockin amplifier was adjusted until a 100-fF capacitance step (built into the capacitance compensation circuit) gave no signal in the real trace. Capacitance was then calibrated by this 100-fF signal in the imaginary trace. In cell-attached capacitance recordings, only traces with r.m.s. noise o10 aF were used. Baseline drifts were removed by linear fitting. This was also occasionally necessary in whole-terminal capacitance recordings. Steps were recognized as abrupt changes that were 2.5-fold greater than the noise. Amplitudes were determined by averaging B1-s sections on either side of the step. Fusion pore conductance (G p ) was calculated from the real (Re) and imaginary (Im) traces as G p ¼ Electron microscopy. Tissue slices were fixed in 2% formaldehyde and 2.5% glutaraldehyde (wt/vol) for 2 h, postfixed with 1% osmium tetroxide and 1% potassium ferrocyanide (wt/vol) for 1 h, dehydrated, embedded and sectioned at 100 nm. For immunogold labeling, tissue sections on nickel grids were quenched in a solution of 50 mM glycine, 2.7 mM KCl, 137 mM NaCl and 10 mM phosphate buffer, pH 7.4, blocked with Aurion blocking solution (Electron Microscopy Sciences) for 1 h, and incubated with antibody to Syt IV (diluted 1:50) overnight at 4 1C. Secondary antibody (goat antibody to rabbit IgG, Amersham) conjugated to ultra-small gold particles (Electron Microscopy Sciences) was then incubated for either 2 h at room temperature 20-23 1C or overnight at 4 1C. Ultra-small gold particles were visualized by silver enhancement with the R-Gent SE-EM kit (Electron Microscopy Sciences). Control sections were prepared identically, but without primary antibody. Tissue sections were post-stained with uranyl acetate and lead citrate before viewing in a Philips CM120 transmission electron microscope using an SIS MegaView III digital camera. Each experiment was performed three times, with 32 images being analyzed in each experiment. DCVs were recognized as membranedelimited circles with electron-dense cores. Microvesicles were recognized as small, clear, membrane-delimited circles. DCVs and microvesicles were scored as being labeled if they overlapped with a label particle.
